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Abstract
Background: Apoptotic cell death plays an essential part in embryogenesis, development and
maintenance of tissue homeostasis in metazoan animals. The culmination of apoptosis in vivo is the
phagocytosis of cellular corpses. One morphological characteristic of cells undergoing apoptosis is
loss of plasma membrane phospholipid asymmetry and exposure of phosphatidylserine on the
outer leaflet. Surface exposure of phosphatidylserine is recognised by a specific receptor
(phosphatidylserine receptor, PSR) and is required for phagocytosis of apoptotic cells by
macrophages and fibroblasts.
Results: We have cloned the PSR receptor from Hydra in order to investigate its function in this
early metazoan. Bioinformatic analysis of the Hydra PSR protein structure revealed the presence of
three nuclear localisation signals, an AT-hook like DNA binding motif and a putative 2-oxoglutarate
(2OG)-and Fe(II)-dependent oxygenase activity. All of these features are conserved from human
PSR to Hydra PSR. Expression of GFP tagged Hydra PSR in hydra cells revealed clear nuclear
localisation. Deletion of one of the three NLS sequences strongly diminished nuclear localisation
of the protein. Membrane localisation was never detected.
Conclusions: Our results suggest that Hydra PSR is a nuclear 2-oxoglutarate (2OG)-and Fe(II)-
dependent oxygenase. This is in contrast with the proposed function of Hydra PSR as a cell surface
receptor involved in the recognition of apoptotic cells displaying phosphatidylserine on their
surface. The conservation of the protein from Hydra to human infers that our results also apply to
PSR from higher animals.
Background
Apoptotic cell death plays an essential role in embryogen-
esis, development and maintenance of tissue homeostasis
in metazoan animals. The culmination of apoptosis in
vivo is the phagocytosis of cellular corpses. One morpho-
logical characteristic of cells undergoing apoptosis is loss
in the phospholipid asymmetry of the plasma membrane
and exposure of phosphatidylserine on the outer mem-
brane leaflet. Surface exposure of phosphatidylserine is
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required for phagocytosis of apoptotic cells by macro-
phages and fibroblasts [1,2].
A putative receptor for phosphatidylserine binding was
cloned from human and mouse macrophages [3]. The
receptor (PSR) was identified by phage display as the anti-
gen for a monoclonal antibody generated against stimu-
lated human macrophages. This antibody inhibited
uptake of apoptotic cells by macrophages, fibroblasts and
epithelial cells.
When cells that do not express the receptor and cannot
engulf apoptotic cells normally, like Jurkat T, were tran-
siently or stably transfected with PSR they gained the abil-
ity to phagocytose apoptotic cells in a phosphatidylserine
specific manner. Additionally it was demonstrated that,
dependent on their interaction with phosphatidylserine,
phagocytosing macrophages release cytokines to suppress
the inflammatory response [3]. In further studies it was
shown that the interaction of phosphatidylserine with
PSR is not so much involved in tethering the apoptotic cell
towards the phagocyte but rather needed for ingesting it
[4]. Anti-PSR antibodies prevented the stereospecific
phosphatidylserine dependent uptake of artificial target
particles. Recently it was also supposed that PSR is
involved in annexin-1 mediated apoptotic cell engulf-
ment [5]. New work from Caenorhabditis elegans describes
that embryonic cell corpses persisted for an average of
55% longer in PSR mutants when compared to wild type
animals [6]. Mice deficient in PSR showed a much
stronger phenotype. They died shortly after birth due to
respiratory failure and exhibited an accumulation of non-
ingested dying cells in the lung together with the recruit-
ment of inflammatory leukocytes. They also showed
hyperblastic brain malformations that in some aspects
were similar to such observed in caspase-9 and APAF-1
knockout mice [7-9].
A very striking feature of PSR is its enormous conservation
between mammals, flies and nematodes. This initiated
our interest in the question of whether this protein was
also present in Hydra and if conservation of its function
was preserved.
We identified a Hydra  cDNA encoding PSR with high
homology to the mammalian, C. elegans and Drosophila
genes. Absolutely conserved between PSR from all species
are three nuclear localisation signals and an AT-hook
DNA binding motif. In accordance with this we found
Hydra  PSR localised in the nuclei of transfected Hydra
cells. Mutation of one of its nuclear localisation signals
blocked this localisation. We have also identified a strik-
ing structural homology of all PSRs with the enzymatic
domain of FIH-1 (factor inhibiting HIF) which has a
2OG-and Fe(II)-dependent oxygenase activity [10]. Our
data suggest that the primary function of PSR in Hydra is
nuclear and not directly linked to phagocytosis. This idea
may also apply to mammalian PSR. Very recent work
shows nuclear localisation for human PSR in a number of
mammalian cell lines [11].
Results and Discussion
Isolation and characterisation of a Hydra homologue of 
PSR
We first isolated Hydra PSR using sequence information
from an alignment of human and mouse PSR with the
predicted ORFs from Drosophila  and  Caenorhabditis ele-
gans. Degenerated primers were designed and RT-PCR was
carried out with hydra mRNA as template. PCR revealed a
0.5 kb product. It contained an ORF that showed substan-
tial homology with the published PSR sequence. We
labelled the PCR product with DIG and used it as a probe
to screen a cDNA library. We obtained a full-length Hydra
PSR clone.
Fig. 1 shows an alignment of Hydra PSR with PSR from
human, mouse, Drosophila and Caenorhabditis elegans. The
middle part of the molecule (red box) comprises the
region with most conservation between species and con-
tains a very ancient structurally conserved domain, the
cupin fold. It is characterized by a β-barrel structure and
has been found in prokaryotic and eukaryotic proteins
including metalloenzymes, sugar binding proteins and a
number of seed storage proteins (for review see [12]).
More recently this cupin fold was detected in members of
the jumonji (JmjC) family of transcription factors [13].
Comparing domain structures of proteins containing
JmjC domains revealed striking similarity of PSR with the
HIF-inhibitory protein (FIH, factor inhibiting HIF, Gen-
Bank accession number Q9NWT6 [14]). Both, PSR and
FIH contain only one JmjC domain. The structure of
human FIH-1 has recently been solved. The core of FIH-1
forms a β-barrel structure (Fig. 2). It also contains a H-X-
D/E dyad and a histidine residue located C-terminally of
this motif [15,16]. These are features of a number of Fe(II)
dependent enzymes that oxidise peptide substrates and 2-
oxoglutarate using O2. In accordance with this structure it
has been shown that FIH-1 is able to hydroxylate a specific
asparagine residue within the transactivation domain of
its substrate, HIF (hypoxia inducing factor). This allows
the regulation of HIF activity in response to oxygen.
We analysed the secondary structure of Hydra PSR using
the program PredictProtein [17]. Figure 3 shows an align-
ment of the FIH-1 β-barrel with the corresponding region
in Hydra PSR. Arrows indicate extended β-strands as they
were predicted by PredictProtein  for PSR; extended β-
strands for FIH-1 were taken from the published crystal
structure [15]. There is an obvious similarity in the
arrangement of β-strands between the central domain ofBMC Cell Biology 2004, 5 http://www.biomedcentral.com/1471-2121/5/26
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PSR and FIH-1 (Fig. 3). Moreover, closer analysis of the 3-
D structure of the β-barrel that is formed by the depicted
β-strands of FIH-1 revealed the hydrophobic residues that
stabilise the barrel (Fig. 2 and 3). These are also conserved
between PSR and FIH-1, making it very likely that the con-
served core domains of both proteins adapt the same fold.
Moreover, amino acids that are diagnostic for 2-OG and
Fe(II)-dependent oxygenases are conserved (e.g. the H-X-
D dyad, that coordinates the catalytic Fe (II) is represented
by H199 and D201 in FIH-1 and by H187 and D189 in
PSR, and the C-terminal histidine H279 in FIH-1 that cor-
responds to H272 in PSR, moreover a lysine residue that
binds 2-OG, K214 in FIH-1 and K204 in PSR) [18]. In
addition, residues T196 in FIH-1 (=T184 in PSR) and
N294 in FIH-1 (=N286 in PSR) in the active site are also
conserved, whereas the neighbouring residues that line
the active site pocket differ and N205 and F207 in FIH-1
correspond to A195 and N197 in PSR. This strongly sug-
gests that the core domain of PSR could catalyse a similar
oxidative reaction as FIH-1 or other members of the
enzyme superfamily. The differences in the active site
pocket, however indicate that PSR most likely has a differ-
ent substrate specifity. Experimental proof for this predic-
tion has to await the identification of a substrate for such
an activity.
PSR shows additional sequence motifs. N-terminally to
the central enzymatic domain the motif KTVRGRPKLS is
found. It is completely conserved in PSR from Hydra to
Homo sapiens (except an R-K exchange on position 4 in
Caenorhabditis elegans) and has high similarity with an AT-
hook motif. This is a short DNA binding motif first
described in the high mobility group of non-histone chro-
mosomal proteins (HMG). Since then it has been discov-
ered in a large number of DNA binding proteins [19]. The
motif is centred on the three amino acids GRP that are
necessary and sufficient to bind to DNA.
Another conserved feature in PSR from Hydra to human
are several putative nuclear localisation signals. They are
(141) PKKRK (145) and (167) KRRPP (171) in the pre-
dicted cytoplasmic domain and (377) KRRK (380) in the
predicted extracellular domain (illustrated in Fig. 1).
In Fig. 1 we have also indicated the putative transmem-
brane domain that was postulated by Fadok [3]. However,
Hydra PSR sequence Figure 1
Hydra PSR sequence Clustal alignment of PSR sequences from Hydra (H. vul, accession number AY559448), Caenorhabditis 
elegans (C. ele, NP500606), Drosophila (D. mel, NP651026), mouse (M. mus, AK122317.1) and human (H. sap, BAA25511). The 
JmjC domain is labelled with a red box, AT-Hook with a blue box. The putative nuclear localisation signals are depicted in 
green. A black dotted box encircles the previously postulated transmembrane domain [3].
postulated transmembrane domain
NLS 3
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none of the transmembrane prediction programs we used
(see Methods) could identify a transmembrane domain in
this region or anywhere else in the hydra PSR molecule.
This prompted us to investigate the subcellular localisa-
tion of this protein. Based on the described function of
human PSR in phagocytosis a membrane association was
expected.
Subcellular localisation of PSR and its NLS-mutants
We expressed both, N-terminal (GFP-PSR) and C-terminal
(PSR-GFP) GFP fusion proteins with PSR in hydra under
the control of an actin promoter (Böttger 2002). Subcellu-
lar localisation of the GFP-fusion proteins was observed
in living animals (Fig. 4) and also after fixation (Fig. 5).
Both fusion proteins were clearly localised to the nucleus
of hydra epithelial cells (Fig. 4A,4B and 4C and Fig. 5A
and 5B). For comparison nuclear staining was also
applied (SYTO-15 in Fig. 4A and TO-PRO-3 in Fig. 5A and
5B). In order to look for membrane localisation we used
the vital membrane stain FM-464 (Molecular Probes) on
non-fixed animals (Fig. 4B and 4C). No GFP co-localised
with membranes.
As described above, the PSR protein contains 3 putative
nuclear localisation signals (Fig. 1). After deletion of NLS
Conserved hydrophobic residues between human FIH-1 and Hydra-PSR Figure 2
Conserved hydrophobic residues between human FIH-1 and Hydra-PSR Ribbon diagram of the conserved core 
domain (amino acids W179 to K298) of the human FIH-1 structure (structure from [15] using RIBBON (Carson 1997). The 
active site residues H199, D201 and H272 in FIH are highlighted in blue. The hydrophobic residues that are conserved 
between Hydra-PSR and human FIH-1 are highlighted in magenta.
H199
D201
H279BMC Cell Biology 2004, 5 http://www.biomedcentral.com/1471-2121/5/26
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1 or NLS 2, nuclear localisation could still be observed
(Fig. 5C and 5D). Deletion of both these NLS sequences
did not change the nuclear localisation of the protein
either (Fig. 4D). However, deletion of the most C-termi-
nal NLS compromised nuclear localisation of the fusion
protein dramatically. This is depicted in Fig. 4E and 4F
and in Fig. 5E. In GFP-PSR∆NLS3 GFP is distributed
throughout the cell, both in fixed and in non-fixed hydra
cells. An additional GFP fusion protein only containing
the JmjC domain of PSR is localised in the same way (not
shown). Interestingly, although not nuclear, these
mutants are not localised to the membrane either.
From these data we concluded that Hydra PSR is normally
localised in the nucleus. Nuclear localisation depends on
a C-terminal nuclear localisation signal. The nuclear func-
tion of this protein has still to be established. The pres-
ence of an AT-hook in the sequence suggests an
attachment to DNA. More strikingly, the putative dioxyge-
nase activity of this molecule that is inferred by compari-
son of its sequence and secondary structure with FIH-1,
could point to a function in the regulation of nuclear pro-
teins by hydroxylation. This regulation would be depend-
ent on the concentration of oxygen, as it has been
described for FIH-1 and oxygen dependent activation of
HIF.
The question remained, if Hydra PSR also has a function
in phagocytosis. We followed the fate of GFP-PSR in trans-
fected hydra cells after induction of apoptosis with
colchicine or with the PI(3) kinase inhibitor wortmannin.
Both treatments lead to massive apoptosis of interstitial
cells in Hydra [20]. These dying cells display phosphati-
dylserine on their surface and are phagocytised by epithe-
lial cells. This was demonstrated by staining apoptotic
hydra cells with annexin-V-fluorescin (Fig. 6). We could
not observe a change in the nuclear localisation of GFP-
PSR in epithelial cells that were in the process of phago-
cytising apoptotic cells. Figure 7 shows an epithelial cell
that has ingested two apoptotic cells and appears to be in
the process of phagocytising one more that is in its close
proximity. GFP-PSR is still present in the nucleus and no
GFP-PSR is localised to the membrane.
Conclusions
Our results clearly contradict a primary function for Hydra
PSR as a membrane receptor involved in phagocytosis. We
suggest that it is a nuclear dioxygenase that is capable of
modifying nuclear proteins. We can, however, not exclude
that the protein excerts an indirect effect on apoptosis and
phagocytosis. The implied oxygen dependence of its puta-
tive enzymatic activity could interact with apoptotic
mechanisms. This would also provide an additional
explanation for the dramatic effect on lung development
observed in PSR knockout mice [8]. In order to under-
stand the function of PSR its intracellular targets will have
to be identified.
Methods
Cloning of Hydra PSR
Degenerated primers were designed on the basis of the
sequence homologies between PSR from human to
Caenorhabditis elegans.
Primer 2 (forward): AARATGAARATGAARTAYTA
Primer 5 (reverse): NACNACRTGCCACCANCC
RT-PCR using hydra cDNA as a template revealed a 0.5 kb
fragment. After sequencing this fragment was labelled
Alignment of the conserved core of human FIH-1 with the homologous region from Hydra-PSR Figure 3
Alignment of the conserved core of human FIH-1 with the homologous region from Hydra-PSR Alignment of the 
conserved core of human FIH-1 forming the central β-barrel structure that harbours the active site with the homologous 
region from Hydra-PSR. Extended β-strands are depicted by blue arrows, for Hydra-PSR above the sequence, for human FIH 
underneath and numbered according to the published crystal structure [15]. Yellow boxes indicate the residues necessary to 
complex the active site Fe2+ ion, violet box indicates the lysine implicated in 2-oxo-glutarate binding. The hydrophobic residues 
that stabilise the barrel structure are highlighted in grey. Stars indicate residues within 4 Angstrom of the catalytic H-X-D that 
constitute the active site.
KRRPPYRWIVIGPARSGTGIHIDPLGTSAWNALISGHKRWMMFPTETPKHLLEVSKQDGQHQSGE 
WGQLTSNLLLIGMEGNVTPAHYDEQ--QNFFAQIKGYKRCILFPPDQFECLYPYPVHHPCDRQSQ
GIQWFVKVYPKVKSPTWPKEYAPLEIIQHPGETVFVPGGWWHVVLNL-DQTVAVTQNF
-VDFDNPDYERFPNFQNVV---GYETVVGPGDVLYIPMYWWHHIESLLNGGITITVNFWYK
        PSR (hydra)
        FIH-1(homo)
167
179
287
 298
β7 β8 β9 β10
β11 β12 β13 β14
        PSR (hydra)
        FIH-1(homo)
*     *   *           *   * 
* *
* *BMC Cell Biology 2004, 5 http://www.biomedcentral.com/1471-2121/5/26
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with DIG and used to screen a Hydra cDNA library as
described previously [20]. The sequence has been submit-
ted to GenBank (accession number AY559448).
PSR localisation in living animals Figure 4
PSR localisation in living animals Single optical sections of GFP expressing cells of living hydra after transfection with GFP-
PSR (A and B), PSR-GFP (C), NLS-mutants ∆NLS1-2 (D) and ∆NLS3 (E and F). Left hand panels show GFP, middle panels 
nuclear staining with SYTO-15 or membrane staining with FM-464 as indicated. Right hand panels are merged images. V indi-
cates vacuoles typically seen in living hydra cells.
A
D
C
B
E
GFP-PSR
PSR-GFP
GFP-PSR ∆ 1-2
GFP-PSR ∆3
FM-464
SYTO-15 merge
merge
merge
merge
merge GFP-PSR
GFP-PSR ∆3
merge
FM-464
FM-464
FM-464
SYTO-15 F
20 µm
V
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Cloning of psr-gfp fusions in the EGFP expression vector 
[21]
First a Sma I-site was introduced into the vector 5' to the
gfp-sequence by site directed mutagenesis. For PSR-GFP
fusion proteins the psr sequence was introduced into this
Sma1-site. For GFP-PSR fusion proteins it was cloned into
the EcoR I-site. The STOP-codon 5' of this site was then
removed by site-directed mutagenesis. This created a short
linker between GFP and PSR encoding for the amino acids
IAFVAF.
NLS-mutants were introduced by site directed mutagene-
sis. In ∆NLS1 amino acids 142–145 (KKRK) were deleted,
in  ∆NLS2 amino acids 166–168 (KRR) and in NLS∆3
amino acids 377–380 (KRRK). The double mutant ∆1,2
was constructed by deleting amino acids 166–168 in
∆NLS 1.
DNA was introduced into hydra cells using a particle gun
as described previously [21].
PSR localisation in fixed animals Figure 5
PSR localisation in fixed animals Single optical sections of GFP-PSR (A), PSR-GFP (B) and single NLS-mutants ∆NLS 1, 2 
and 3 in single GFP expressing cells after fixation (C-E). Left hand panels detect GFP, middle panels DNA-staining with TO-
PRO and right hand panels represent merged images. Nuclear morphology is typical for hydra epithelial cells after fixation. 
Note that nucleoli are not stained with TO-PRO (middle panel) and also free of GFP (left hand panel).
A
D
C
B
E
GFP-PSR
PSR-GFP
GFP-PSR ∆2
merge
merge
merge
merge
merge
GFP-PSR ∆1
10 µm
TO-PRO-3
TO-PRO-3
TO-PRO-3
TO-PRO-3
TO-PRO-3
GFP-PSR ∆3BMC Cell Biology 2004, 5 http://www.biomedcentral.com/1471-2121/5/26
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Confocal imaging
Living animals with GFP expressing cells were stained
with FM-464 (Molecular Probes) for detection of plasma
membranes or SYTO-15 for nuclear staining, treated with
urethane and scanned immediately. Fixation was carried
out with 2% paraformaldehyde in PBS for 1 h. Fixed ani-
mals were counterstained for DNA with TO-PRO-3
(Molecular Probes) and mounted on slides with
VECTASHIELD mounting medium (Alexis Biochemicals).
Light optical serial sections were acquired with a Leica
(Leica Microsystems, Heidelberg, Germany) TCS SP con-
focal laser scanning microscope equipped with an oil
imersion Plan-Apochromat 100/1.4 NA objective lens.
Fluorochromes were visualized with an argon laser with
excitation wavelengths of 488 nm, 488 nm, 514 and emis-
sion filters 520–540 nm, 550–700 nm and 530–550 for
EGFP, FM-464 and SYTO-15 respectively, and with a
helium-neon laser with excitation wavelength 633 nm,
emission filter 660–760 nm (for TO-PRO-3). Two fluoro-
chromes and the phase contrast image (transmission fil-
ter) were scanned sequentially. Image resolution was 512
× 512 pixel with a pixel size ranging from 195 to 49 nm
depending on the selected zoom factor. The axial distance
between optical sections was 200 nm for zoom factor 4
and 1 µm for zoom factor 1. To obtain an improved sig-
nal-to-noise ratio each section image was averaged from 4
successive scans. The 8 bit greyscale single channel images
were overlayed to an RGB image assigning a false colour
to each channel, and then assembled into tables using
Adobe Photoshop 5.5.
Apoptosis was induced with 1 µM wortmannin for 4
hours before cells were analysed. For annexin-V-fluorescin
staining apoptosis was induced with 0.4% colchicine for
6 hours. Animals were then dissociated with pronase [20]
and incubated with annexin-V-fluorescin and PI. The two
fluorochromes and the phase contrast were scanned as
described above.
Structural predictions
PSORT II[22] was used to predict the nuclear localisation
signals. The same program did not predict an N-terminal
signal peptide or transmembrane domain for the thresh-
old 0.5. Furthermore for prediction of transmembrane
domains we used Toppred 2 [23] for eukaryotic cells with
the default settings (Cutoff for certain transmembrane
segments: 1.00, Cutoff for putative transmembrane seg-
ments: 0.60, Critical distance between 2 transmembrane
segments: 2, Critical loop length: 60.) and TMHMM [24],
also with default settings.
Abbreviation
PSR phosphatidylserine receptor
Phosphatidylserine on the extracellular face of apoptotic  hydra cells Figure 6
Phosphatidylserine on the extracellular face of apop-
totic hydra cells (A) annexin-V-fluorescin label of a hydra 
cell after induction of apoptosis with colchicine, (B) phase 
contrast image of the cell, (C) absence of propidium iodid 
(PI) staining: PI can only enter cells after membrane integrity 
is lost, absence of PI staining indicates that annexin-V-fluo-
rescin binds the extracellular face of the membrane.
A
B
C
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GFP green fluorescent protein
EGFP enhanced GFP
ORF open reading frame
NLS nuclear localisation signal
HIF hypoxia inducing factor
FIH-1 factor inhibiting HIF
2-OG 2 oxoglutarate
PI propidium iodid
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PSR stays in the nucleus of phagocytising cells Figure 7
PSR stays in the nucleus of phagocytising cells Hydra epithelial cell expressing GFP-PSR in the nucleus. The cell has 
engulfed two apoptotic cells with pycnotic nuclei (red circles). Two additional apoptotic cells are still on the outside of the cell 
surrounded by its membrane (red circles). They are apparently in the process of being phagocytised. Apoptosis was induced 
with wortmannin. Single sections of confocal images are shown: (A) phase contrast, (B) merged image from (C) and (D), (C) 
TO-PRO-DNA staining, (D) GFP. In (A) a green line marks the outline of the transfected cell. Yellow arrow indicates the gold 
particle. Scale bar 10 µm.
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